Table 1 Baseline demographic and clinical characteristics (ITT population)
From: A randomized placebo-controlled phase II study of a Pseudomonas vaccine in ventilated ICU patients
Parametera | IC43 100 μg with adj N = 104 | IC43 100 μg w/o adj N = 98 | IC43 200 μg with adj N = 101 | Placebo N = 98 | Total N = 401 |
|---|---|---|---|---|---|
Age (years) | 57.0 (16.2) | 54.3 (15.3) | 55.2 (15.7) | 58.1 (15.3) | 56.1 (15.6) |
Weight (kg) | 82.0 (19.2) | 84.6 (17.6) | 82.5 (17.9) | 82.5 (21.7) | 82.9 (19.1) |
Height (cm) | 170.8 (10.5) | 173.5 (9.1) | 171.5 (8.2) | 171.5 (10.0) | 171.8 (9.5) |
Sex | |||||
Male | 64 (61.5) | 70 (71.4) | 72 (71.3) | 61 (62.2) | 267 (66.6) |
Female | 40 (38.5) | 28 (28.6) | 29 (28.7) | 37 (37.8) | 134 (33.4) |
Race | |||||
Caucasian | 95 (91.3) | 93 (94.9) | 94 93.1) | 92 (93.9) | 374 (93.3) |
Asian | 2 (1.9) | 1 (1.0) | 0 (0.0) | 2 (2.0) | 5 (1.2) |
Black | 1 (1.0) | 0 (0.0) | 2 (2.0) | 1 (1.0) | 4 (1.0) |
Other | 6 (5.8) | 4 (4.1) | 5 (5.0) | 3 (3.1) | 18 (4.5) |
HIV status | |||||
Positive | 0 (0.0) | 2 (2.0) | 0 (0.0) | 0 (0.0) | 2 (0.5) |
Missing | 2 (1.9) | 1 (1.0) | 3 (3.0) | 3 (3.1) | 9 (2.2) |